Trastuzumab plus docetaxel in patients with advanced HER2-positive salivary duct carcinoma: Exploratory biomarker analyses
Keyword(s):
Keyword(s):
2019 ◽
Vol 35
(1)
◽
pp. 13-20
2000 ◽
Vol 22
(2)
◽
pp. 135-135
◽